For instance, our findings indicated that the expression levels of G Protein Nucleolar 3 Like (GNL3L), Ankyrin Repeat and MYND Domain Containing 1 (ANKMY1), Host Cell Factor C1 (HCFC1), Nucleolar Protein 9 (NOL9), Inosine Monophosphate Dehydrogenase 2 (IMPDH2), and RNA Polymerase III Subunit C (POLR3C) were significantly up-regulated in AML patients compared to controls (Table S1). The gene discussed is POLR3C; the disease is acute myeloid leukemia.